WASHINGTON/SAN FRANCISCO (Reuters) – Apple cannot sell two flagship Apple Watch models in the U.S. as the iPhone maker fights a legal battle over patents covering a blood oxygen measurement feature, a U.S. appeals court ruled on Wednesday.
Original article here